Welcome New Members June 2021!

Posted by ISPE Boston
On July 2, 2021

We would like to introduce the Members who joined ISPE in June 2021, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Panel Addresses Virtualization in the Post-Pandemic Era

Posted by Sunny Tam
On June 30, 2021

The Virtual Utilization presentation and panel discussion on June 23rd had a great turnout, hitting our capacity limit of 50 attendees! It was invigorating to see people in person again and enjoy the spacious Pavilion Room at Gillette while hearing the New England Revolution soccer game in the background. This event began with a networking […]

Cancer Drug Startup Valo Inks Billion-Dollar SPAC Deal

Posted by ISPE Boston
On June 23, 2021

Boston-based Valo Health has entered into a definitive merger agreement with Khosla Ventures Acquisition Co. (KVAC), a special purpose acquisition company or SPAC. The transaction represents a pro forma market value of approximately $2.8 billion for the combined company. Valo anticipates the pro forma cash balance of the combined company will be approximately $750 million before expenses. Founded by Flagship Pioneering, Valo has built an internal pipeline with two […]

IPOs and Funding Rounds Keep Local Biotechs Busy

Posted by ISPE Boston
On June 23, 2021

Local biotechs have been busy this spring raising funds through highly successful IPOs and funding rounds. Boston-based Talaris Therapeutics’ IPO, which closed on May 11, raised approximately $150 million for the company. Known as Regenerex at its founding in 2002, Talaris, is a late-clinical stage cell therapy company developing an innovative method of allogeneic hematopoietic […]

iTeos and GSK Enter $2.1 Billion Deal

Posted by ISPE Boston
On June 23, 2021

Cambridge-based iTeos Therapeutics and GlaxoSmithKline (GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody currently in phase I development as a potential treatment for patients with cancer. TIGIT, part of the CD226 checkpoint axis, has demonstrated potential as a promising target for the next generation of immuno-oncology therapies based on compelling preclinical […]

Boston Area WIPs Find a New Way to Connect

Posted by Caren Jenkins
On June 17, 2021

Question: What do you get when you combine the first gorgeous summer day, two loveable pups, nine vaccinated WIP members and a beautiful outdoor recreational area with trails, ponds, and trees? Answer: A really good time! On Wednesday June 9, the Boston Area Chapter’s Women in Pharma held their first WIP Walk. Nine WIP members […]

Lexington’s Agenus Licenses Cancer Drug to BMS for 200m

Posted by ISPE Boston
On June 10, 2021

Lexington biotech Agenus has granted Bristol Myers Squibb an exclusive global license for its proprietary bispecific antibody program, AGEN1777, that blocks TIGIT and a second undisclosed target. AGEN1777 is an Fc-enhanced antibody in late preclinical development designed to target major inhibitory receptors expressed on T and NK cells to improve anti-tumor activity. In preclinical studies […]

Biogen Alzheimer’s Drug Wins OK

Posted by ISPE Boston
On June 10, 2021

The FDA has granted accelerated approval to Biogen and Eisai for Aduhelm™ (aducanumab-avwa), a human monoclonal antibody, as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain. Biogen licensed Aduhelm from Neurimmune in 2007 under a collaborative development and license agreement. […]

Hot Competition at Mini-Golf

Posted by Stacey Vega
On June 7, 2021

On May 26th, the ISPE Boston Area Chapter’s Membership Committee hosted the 1st annual Miniature Golf Tournament in beautiful Holliston. Players brought their A game as they battled it out to be at the top of the leader board. The competition was fierce and many holes-in-one were made. Despite the blazing heat, everyone had a […]

Chapter Member Anniversaries: June 2021

Posted by ISPE Boston
On June 4, 2021

Please congratulate the following members celebrating milestone anniversaries in June 2021. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Neil A. Bergeron, Lonza Timothy J. Horgan, Alnylam Pharmaceuticals David L. Hyde, CBA, CPIP, Lantheus Holdings, Inc. Richard G. Kotosky, PE, CPIP Jim F. Mcallister, PTSI Stephen P. […]

Page 46 of 117«‹44 454647 48 ›»